103 related articles for article (PubMed ID: 20967219)
21. Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study.
Shrivastava P; Garg H; Bhat M; Dinda A; Kumar R
Indian J Urol; 2020; 36(1):50-55. PubMed ID: 31983827
[TBL] [Abstract][Full Text] [Related]
22. Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.
Berglund E; Maaskola J; Schultz N; Friedrich S; Marklund M; Bergenstråhle J; Tarish F; Tanoglidi A; Vickovic S; Larsson L; Salmén F; Ogris C; Wallenborg K; Lagergren J; Ståhl P; Sonnhammer E; Helleday T; Lundeberg J
Nat Commun; 2018 Jun; 9(1):2419. PubMed ID: 29925878
[TBL] [Abstract][Full Text] [Related]
23. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Dadaev T; Saunders EJ; Newcombe PJ; Anokian E; Leongamornlert DA; Brook MN; Cieza-Borrella C; Mijuskovic M; Wakerell S; Olama AAA; Schumacher FR; Berndt SI; Benlloch S; Ahmed M; Goh C; Sheng X; Zhang Z; Muir K; Govindasami K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman P; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger G; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West C; Dunning AM; Burnet N; Mucci L; Giovannucci E; Andriole G; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein B; Kerns S; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Fachal L; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weisher M; Bisbjerg R; Røder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo SH; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Slavov C; Mitev V; Parliament M; Singhal S; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw KT; Cannon-Albright L; Pandha H; Michael A; Kierzek A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Kraft P; ; Freedman M; Wiklund F; Chanock S; Henderson BE; Easton DF; Haiman CA; Eeles RA; Conti DV; Kote-Jarai Z
Nat Commun; 2018 Jun; 9(1):2256. PubMed ID: 29892050
[TBL] [Abstract][Full Text] [Related]
24. Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.
Nowinski S; Santaolalla A; O'Leary B; Loda M; Mirchandani A; Emberton M; Van Hemelrijck M; Grigoriadis A
Oncotarget; 2018 Feb; 9(16):12812-12824. PubMed ID: 29560112
[TBL] [Abstract][Full Text] [Related]
25. Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci.
Larson NB; McDonnell SK; Fogarty Z; Larson MC; Cheville J; Riska S; Baheti S; Weber AM; Nair AA; Wang L; O'Brien D; Davila J; Schaid DJ; Thibodeau SN
Oncotarget; 2017 Oct; 8(49):85896-85908. PubMed ID: 29156765
[TBL] [Abstract][Full Text] [Related]
26. Prostate Cancer Germline Variations and Implications for Screening and Treatment.
Dias A; Kote-Jarai Z; Mikropoulos C; Eeles R
Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29101112
[TBL] [Abstract][Full Text] [Related]
27. MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.
Peng T; Zhang L; Zhu L; Mi YY
Oncotarget; 2017 Apr; 8(17):28494-28501. PubMed ID: 28212531
[TBL] [Abstract][Full Text] [Related]
28. Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.
Ahmed M; Eeles R
Future Sci OA; 2016 Mar; 2(1):FSO87. PubMed ID: 28031937
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers for prostate cancer: present challenges and future opportunities.
Sharma P; Zargar-Shoshtari K; Pow-Sang JM
Future Sci OA; 2016 Mar; 2(1):FSO72. PubMed ID: 28031932
[TBL] [Abstract][Full Text] [Related]
30. Reduced Contractility and Motility of Prostatic Cancer-Associated Fibroblasts after Inhibition of Heat Shock Protein 90.
Henke A; Franco OE; Stewart GD; Riddick AC; Katz E; Hayward SW; Thomson AA
Cancers (Basel); 2016 Aug; 8(9):. PubMed ID: 27563925
[TBL] [Abstract][Full Text] [Related]
31. Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview.
Reva S; Nosov A; Novikov R; Petrov S
Int Sch Res Notices; 2014; 2014():243080. PubMed ID: 27351008
[TBL] [Abstract][Full Text] [Related]
32. Overexpression and purification of folded domain of prostate cancer related proteins MSMB and PSA.
Tiwary M; Agarwal N; Dinda A; Yadav SC
Mol Biol Rep; 2016 May; 43(5):349-58. PubMed ID: 27038170
[TBL] [Abstract][Full Text] [Related]
33. Identifying New Candidate Genes and Chemicals Related to Prostate Cancer Using a Hybrid Network and Shortest Path Approach.
Yuan F; Zhou Y; Wang M; Yang J; Wu K; Lu C; Kong X; Cai YD
Comput Math Methods Med; 2015; 2015():462363. PubMed ID: 26504486
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ.
Adamo HH; Halin Bergström S; Bergh A
PLoS One; 2015; 10(6):e0130076. PubMed ID: 26076453
[TBL] [Abstract][Full Text] [Related]
35. An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality.
Sullivan J; Kopp R; Stratton K; Manschreck C; Corines M; Rau-Murthy R; Hayes J; Lincon A; Ashraf A; Thomas T; Schrader K; Gallagher D; Hamilton R; Scher H; Lilja H; Scardino P; Eastham J; Offit K; Vijai J; Klein RJ
Br J Cancer; 2015 Jun; 113(1):166-72. PubMed ID: 26068399
[TBL] [Abstract][Full Text] [Related]
36. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.
Amin Al Olama A; Benlloch S; Antoniou AC; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Muir K; Schleutker J; Henderson BE; Haiman CA; Schumacher FR; Pashayan N; Pharoah PD; Ostrander EA; Stanford JL; Batra J; Clements JA; Chambers SK; Weischer M; Nordestgaard BG; Ingles SA; Sorensen KD; Orntoft TF; Park JY; Cybulski C; Maier C; Doerk T; Dickinson JL; Cannon-Albright L; Brenner H; Rebbeck TR; Zeigler-Johnson C; Habuchi T; Thibodeau SN; Cooney KA; Chappuis PO; Hutter P; Kaneva RP; Foulkes WD; Zeegers MP; Lu YJ; Zhang HW; Stephenson R; Cox A; Southey MC; Spurdle AB; FitzGerald L; Leongamornlert D; Saunders E; Tymrakiewicz M; Guy M; Dadaev T; Little SJ; Govindasami K; Sawyer E; Wilkinson R; Herkommer K; Hopper JL; Lophatonanon A; Rinckleb AE; Kote-Jarai Z; Eeles RA; Easton DF; ; ;
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1121-9. PubMed ID: 25837820
[TBL] [Abstract][Full Text] [Related]
37. MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.
Sutcliffe S; De Marzo AM; Sfanos KS; Laurence M
Prostate; 2014 May; 74(6):569-78. PubMed ID: 24464504
[TBL] [Abstract][Full Text] [Related]
38. The genetic epidemiology of prostate cancer and its clinical implications.
Eeles R; Goh C; Castro E; Bancroft E; Guy M; Al Olama AA; Easton D; Kote-Jarai Z
Nat Rev Urol; 2014 Jan; 11(1):18-31. PubMed ID: 24296704
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.
Robinson JL; Hickey TE; Warren AY; Vowler SL; Carroll T; Lamb AD; Papoutsoglou N; Neal DE; Tilley WD; Carroll JS
Oncogene; 2014 Dec; 33(50):5666-74. PubMed ID: 24292680
[TBL] [Abstract][Full Text] [Related]
40. MSMB gene variant alters the association between prostate cancer and number of sexual partners.
Stott-Miller M; Wright JL; Stanford JL
Prostate; 2013 Dec; 73(16):1803-9. PubMed ID: 24037734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
